Navigation Links
Tiens Biotech Group (USA) Reports Fourth Quarter and Twelve-Month Results
Date:3/28/2008

, net 2,603,084 510,183

Long-term prepaid expenses 5,301,847 7,031,348

Loans receivable - related party -- 25,640,000

Acquisition deposit 71,747,182 --

Total other assets 79,652,113 33,181,531

Total assets $ 181,627,637 $ 148,746,998

TIENS BIOTECH GROUP (USA), INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

AS OF DECEMBER 31, 2007 AND DECEMBER 31, 2006

L I A B I L I T I E S A N D S H A R E H O L D E R S' E Q U I T Y

December 31, December 31,

2007 2006

CURRENT LIABILITIES:

Accounts payable $ 4,070,906 $ 4,123,105

Advances from customers - related

parties 1,700,838 1,570,120

Wages and benefits payable 1,250,685 992,068

Other taxes payable 536,819 93,714

Income taxes payable 665,726 876,046

Other payables 1,133,539 500,213

Other payables - related parties 7,938,205 522,105

Dividend payable to minority interest 4,902,629 238,311

Current portion of long-term debt,

related party 2,130,000 2,130,000

Total current liabilities 24,329,347 11,045,682

NON-CURRENT LIABILITIES:

Long term debt, net of current portion,

related party 4,267,742 6,397,742

Other payables-non-current
'/>"/>

SOURCE Tiens Biotech Group (USA), Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. deCODE genetics to Webcast Presentation at 15th Annual Future Leaders in the Biotech Industry Conference
2. EntreMed to Present at BioCentury Future Leaders in the Biotech Industry Conference
3. Epeius Biotechnologies Awarded U.S. Patent for Targeted Injectable Gene Delivery In Vivo
4. Millennium Biotechnologies, Inc. Signs Marketing and Distribution Agreement with Ferring Pharmaceuticals
5. Accurate Identification of Tumor Origin Using MicroRNAs is Published by Rosetta Genomics Scientists and Collaborators in Nature Biotechnology
6. ITSSD: Russia Can Secure Greatest Biotech Market Advances Following US, Not EU Innovation Model
7. Pharmacopeia to Present at the 15TH Annual Future Leaders in the Biotech Industry Conference
8. SGX Pharmaceuticals to Present at the BioCentury Future Leaders in the Biotech Industry Conference
9. Genetic Engineering & Biotechnology News reports on clinical trials in developing countries
10. Oncolytics Biotech Inc. Announces Issuance of 26th U.S. Patent
11. ProMetic and Sartorius Stedim Biotech collaborate on technology transfer deals in Asia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)..., COLUMBIA, Md., Dec. 2 ...nnounced today that it intends to release the resu...December 16, 2009, at approximately 4:00 p.m. East.... ET Martek will conduct a conference call to disc...parties may listen to the call live via webcast by...
(Date:12/2/2009)... , NEW YORK, Dec. 2 Reportlink... is available in its catalogue: ,, Drug Discov...s & Opportunities ,, http://www.reportlin...lobal-Update-of-Market-Trends--Opportunities.html ...ngoing element of every pharmaceutical company,s b...
(Date:12/2/2009)... , CALGARY, Dec. 2 /PRNewswire-FirstCall/ - O...ny") (TSX:ONC; NASDAQ: ONCY ) announced today that...offering, the underwriters have exercised in full ...ional 637,500 units. Each unit is comprised of one...arrant, and was sold at a price of US$3.00 per uni...
(Date:12/2/2009)... , JERUSALEM, Israel, December 2 /PRNewsw...study evaluating the preclinical (animal study) sa...combines technology from Weill,Cornell Medical Col...al to,treat inherited anemias such as Cooley,s Ane... of technologies to expand, ex vivo,populations o...
Breaking Biology Technology:Martek to Announce Fourth Quarter and Fiscal Year 2009 Results 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3
...ael and JERSEY CITY, New Jersey, November 3, Roset... development of microRNA-based diagnostics, announ...ference "Translational Cancer Medicine,2008: Bridg...ar Diagnostics,in Cancer Therapeutic Development c...ber 3-6, at the ICC Jerusalem International Conven...
... Pa., Nov. 3 Environmental,Tectonics Corporation,...n,Division today announced the signing of a contra..., to add new capabilities to their ADMS-ARFF,Advan...cue Fire Fighting., The contract consists of the ...consisting of AH-64 Apache helicopters parked in a...
...a from randomized, double-blind, placebo controlle...ignificant reduction in recurrences ...AICA PLAIN, Mass., Nov. 3 /PRNewswire-FirstCall/,-...etts Biologic Laboratories,(MBL) of the University...unced that a Phase 2 trial of an anti-C. difficile...
Other Biology Technology:Rosetta Genomics to Present at the American Association of Cancer Research (AACR) Centennial Conference 2Rosetta Genomics to Present at the American Association of Cancer Research (AACR) Centennial Conference 3Environmental Tectonics Corporation's Simulation Division Receives New ADMS Contract from Netherlands Institute for Safety 2Environmental Tectonics Corporation's Simulation Division Receives New ADMS Contract from Netherlands Institute for Safety 3Medarex and Massachusetts Biologic Laboratories Announce Primary Objective Achieved in Phase 2 Trial of Monoclonal Antibody Combination for the Treatment of Clostridium difficile Associated Diarrhea (CDAD) 2Medarex and Massachusetts Biologic Laboratories Announce Primary Objective Achieved in Phase 2 Trial of Monoclonal Antibody Combination for the Treatment of Clostridium difficile Associated Diarrhea (CDAD) 3Medarex and Massachusetts Biologic Laboratories Announce Primary Objective Achieved in Phase 2 Trial of Monoclonal Antibody Combination for the Treatment of Clostridium difficile Associated Diarrhea (CDAD) 4Medarex and Massachusetts Biologic Laboratories Announce Primary Objective Achieved in Phase 2 Trial of Monoclonal Antibody Combination for the Treatment of Clostridium difficile Associated Diarrhea (CDAD) 5Medarex and Massachusetts Biologic Laboratories Announce Primary Objective Achieved in Phase 2 Trial of Monoclonal Antibody Combination for the Treatment of Clostridium difficile Associated Diarrhea (CDAD) 6
(Date:12/3/2009)...QUE, N.M. Most scientists believe that staph infe...nal each other to emit toxins. The signaling proce...must be present to start the process. , But the ...e very first stage of staph infection, when bacter...rs in a single cell and that this individual proce...
(Date:12/3/2009)...researchers have measured CO2 levels for the past ...over a sparsely inhabited rural area near Valladol... in the Iberian Peninsula, show that the levels ro... recent years, physicists and meteorologists have ... levels, and how these have evolved in the troposp...
(Date:12/2/2009)...ELPHIA Less acculturated Latino men have a more d...more acculturated to U.S. culture, but acculturati...ng. Details of these findings are published in Ca...rnal of the American Association for Cancer Resear...cco. , "Acculturation affects smoking cessation ...
Breaking Biology News(10 mins):Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 2Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 3CO2 levels rising in troposphere over rural areas 2Acculturation affects smoking cessation success among Latinos 2The Brain Comes Alive With the Sounds of Music 59818 1The Brain Comes Alive With the Sounds of Music 59818 2Full Results of AIDS Vaccine Trial Confirm Modest Benefit 59816 1Full Results of AIDS Vaccine Trial Confirm Modest Benefit 59816 2Full Results of AIDS Vaccine Trial Confirm Modest Benefit 59816 3Full Results of AIDS Vaccine Trial Confirm Modest Benefit 59816 4Henk Stunnenbergs lab applies Genomatix NextGen sequencing data analysis 59814 1
...DISON, WI, JUNE 2, 2008-- An understanding how env...teract to determine the transport and fate of agri... for effectively addressing the widespread degrada...nt, and future agricultural activities. While cons...maller scales, the holistic understanding of proce...
... team of Penn State scientists has discovered a ne...d for more than 120,000 years within the ice of a ... The microorganism,s ability to persist in this lo...nutrient-poor habitat makes it particularly useful... a variety of extreme environments on Earth and po...
...hens, Ga. The conventional wisdom among scientist...bacteria that are necessary for good health from t...study finds that chickens are actually born with t... the finding, presented this week at the American ..., could have important implications for the poultr...
Other Biology News:Holistic understanding: Ag chemicals in the environment 2A survivor in Greenland: A novel bacterial species is found trapped in 120,000-year-old ice 2Study finds healthy intestinal bacteria within chicken eggs 2
Rabbit Anti-Human Cytochrome P450 1A1 / 1A2 Polyclonal Antibody, Unconjugated from AbD Serotec
...-free cloning of BAC (100+kb), fosmid (40kb), and ...t stability than any othe BAC vector. On command 2...asy recombinant DNA purification. Available with b...e (pSMART VC) vectors for the highest insert stabi...
...-free cloning of BAC (100+kb), fosmid (40kb), and ...t stability than any othe BAC vector. On command 2...asy recombinant DNA purification. Available with b...e (pSMART VC) vectors for the highest insert stabi...
Rabbit Anti-GLYCINE Polyclonal Antibody, Unconjugated from AbD Serotec
Biology Products: